Expression of the Partial B Antigen of the Marek’s Disease Virus in E. coli

li boliang,chen puyan,ma zhiyong,yang xinying,yang yi,wu xianfu,jin youxin,cai baoxiang,wang debao
1994-01-01
Abstract:A 764 hp ScaI-SphI DNA fragment containing the sequence encoding the partial extracellular domain of the Marek’s disease virus antigen B (MDV-B)was isolated from the I3 fragment of the BamHI-MDV genomic library and cloned into the HineII--SpbI sites of phage M 13 mp 19, and then eonfirmed to be the sequence 494-1258 hp of MDV-B gene by DNA sequencing. The plasmid PBLMDB 2 for expressing a partial fragment of extracellular domain (246 ̄420amino acid sequence) of MDV-B antigen was eonstructed by inserting a 530 bp NcoI-HindlIII frsgment obtained from the above M 13 recombinant into the vector whieh contained a modified cIts 857 gene and PL Promoter of phage λ for controlling the expression of a foreign gene, as well as creating TAG stop codon at 3’-terminus Of this fragment. By the analysis of SDS-PAGE, the product of interest accounting for 15% of the total bacterial proteins yielded was observed in E. coli BL 21 harboring the plasmid PBLMDB2 induced at 42℃. The expressed produet aggregated insolubly as the inclusion body and was purified to over 80%purity by the method for preparing the inclusion body. Identification of the purified product demonstrated that its immunologiceal specificity was well retained and the N-terminal 20 amino acid eequenoe was the same as that expected from the DNA sequence. The immunofluorescence tests using the antisera to the above expressed product revealed the virus-specific antigen on the CEF cell infected by MDV 11.
What problem does this paper attempt to address?